Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dihydroartemisinin Affects STAT3/DDA1 Signaling Pathway and Reverses Breast Cancer Resistance to Cisplatin
Jing Zhang, Yang Li, Ji-guo Wang, et al.
The American Journal of Chinese Medicine (2023) Vol. 51, Iss. 02, pp. 445-459
Closed Access | Times Cited: 11

Showing 11 citing articles:

Terpenoid-Mediated Targeting of STAT3 Signaling in Cancer: An Overview of Preclinical Studies
Fahad Khan, Pratibha Pandey, Meenakshi Verma, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 200-200
Open Access | Times Cited: 10
Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer
Yanping Li, Haoyi Sun, Caihong Bai, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112157-112157
Closed Access | Times Cited: 4
The Role of CXCL13 in GC‐1 Cell Cycle Arrest Induced by Titanium Dioxide Nanoparticles Through JAK2/STAT3 Signaling Pathway
Yuzhu Lei, Ruoyun Dong, Chun-Yan Sun, et al.
Journal of Applied Toxicology (2025)
Closed Access
Revealing the Role of Beesioside O from Actaea vaginata for the Treatment of Breast Cancer Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
Shuyang Li, Juan Lü, Hongwei Xue, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2283-2283
Open Access
Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways
Chi Teng, Jiawen Chen, Lisha Shen, et al.
Cancer Drug Resistance (2025)
Open Access
Dihydroartemisinin inhibited stem cell‐like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT/mTOR signaling
Yujun Wang, Zhirong Yang, Wanglong Zhu, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 988-998
Closed Access | Times Cited: 7
Addressing the mean-variance relationship in spatially resolved transcriptomics data with spoon
Kinnary H Shah, Boyi Guo, Stephanie C. Hicks
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Dihydroartemisinin inhibits liver cancer cell migration and invasion by reducing ATP synthase production through CaMKK2/NCLX
Jiang Chang, Chengyi Xin, Yong Wang, et al.
Oncology Letters (2023) Vol. 26, Iss. 6
Open Access | Times Cited: 3
Exosomes Improved the in Vitro Anti-Melanoma Efficacy of Dihydroartemisinin
Dulla Naveen Kumar, Aiswarya Chaudhuri, Deepa Dehari, et al.
(2024)
Closed Access
Dihydroartemisinin, an artemisinin derivative, reverses oxaliplatin resistance in human colorectal cancer cells by regulating the SIRT3/PI3K/AKT signalling pathway.
X Shen, Chencheng Shi, Ming Lei, et al.
Investigación Clínica (2024) Vol. 65, Iss. 3, pp. 267-278
Open Access
Research Progress of Traditional Chinese Medicine in Treating Central Nervous System Diseases by Modulating Ferroptosis
Zelu Zhou, Yanlan YU, Jianhua Miao, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 07, pp. 1989-2019
Closed Access
Page 1

Scroll to top